Ignite Creation Date:
2024-05-06 @ 7:38 PM
Last Modification Date:
2024-10-26 @ 3:10 PM
Study NCT ID:
NCT06074588
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-10-03
Brief Title:
Sacituzumab Tirumotecan MK-2870 Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer NSCLC With EGFR Mutations or Other Genomic Alterations MK-2870-004
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC